- Q4 2023 PDS Biotechnology Corp Earnings Call TranscriptMar 27, 2024€4.13 (-4.95%)Earnings
- Q3 2023 PDS Biotechnology Corp Earnings Call TranscriptNov 14, 2023€4.85 (+7.55%)Earnings
- PDS Biotechnology Corp To Host Key Opinion Leader Roundtable TranscriptOct 03, 2023
- PDS Biotechnology Corp at Cantor Fitzgerald Global Healthcare Conference TranscriptSep 26, 2023
- Q2 2023 PDS Biotechnology Corp Earnings Call TranscriptAug 14, 2023€4.37 (-0.11%)Earnings
- PDS Biotechnology Corp To Host Post ASCO Call TranscriptJun 06, 2023
- Q1 2023 PDS Biotechnology Corp Earnings Call TranscriptMay 15, 2023€5.86 (-0.34%)Earnings
- PDS Biotechnology Corp To Host Key Opinion Leader Call TranscriptApr 21, 2023
- Q4 2022 PDS Biotechnology Corp Earnings Call TranscriptMar 28, 2023€5.37 (+0.75%)Earnings
- PDS Biotechnology Corp at Noble Capital Markets Takeaway Series on Channelchek- J.P. Morgan Healthcare Conference TranscriptJan 26, 2023
- PDS Biotechnology Corp Announces Exclusive Global License Agreement for Investigational IL-12 Tumor-Targeted Cytokine TranscriptJan 03, 2023
- Q3 2022 PDS Biotechnology Corp Earnings Call TranscriptNov 14, 2022€5.37 (-1.29%)Earnings
- PDS Biotechnology Corp Head And Neck Cancer KOL Roundtable TranscriptOct 26, 2022
- PDS Biotechnology Corp Update Call TranscriptAug 25, 2022
- Q2 2022 PDS Biotechnology Corp Earnings Call TranscriptAug 08, 2022€5.16 (+1.38%)Earnings
- PDS Biotechnology Corp Post ASCO Call TranscriptJun 07, 2022
- Q1 2022 PDS Biotechnology Corp Earnings Call TranscriptMay 11, 2022€4.18 (-1.90%)Earnings
- Q4 2021 PDS Biotechnology Corp Earnings Call TranscriptMar 31, 2022Earnings
- PDS Biotechnology Corp Extraordinary Shareholders Meeting TranscriptJan 19, 2022
- Q3 2021 PDS Biotechnology Corp Earnings Call TranscriptNov 10, 2021€8.84 (-4.93%)Earnings
- Q2 2021 PDS Biotechnology Corp Earnings Call TranscriptAug 12, 2021€8.93 (-2.75%)Earnings
- PDS Biotechnology Corp Oncology R&D Day TranscriptJun 16, 2021
- PDS Biotechnology Post-ASCO Conference Call - Corporate Analyst Meeting TranscriptJun 08, 2021
- Q1 2021 PDS Biotechnology Corp Earnings Call TranscriptMay 13, 2021€3.61 (+0.47%)Earnings
- Q2 2020 PDS Biotechnology Corp Earnings Call TranscriptAug 13, 2020€2.38 (-1.65%)Earnings
PDS Biotechnology Corp Update Call Transcript
Greetings, and welcome to the PDS Biotechnology Financing Conference Call.(Operator Instructions) As a reminder, this conference is being recorded. It is now my pleasure to introduce your host, Gabby DeGravina of Investor Relations. Thank you. Please go ahead.
Good morning, and welcome to PDS Biotech financing conference call. With me today from the company are Dr. Frank Bedu-Addo, Chief Executive Officer; and Matt Hill, Chief Financial Officer. Yesterday afternoon, PDS Biotech issued a press release announcing that the company completed a debt financing agreement. We encourage everyone to read the press release as well as PDS Biotech's Form 8-K, which includes other updates and was also issued yesterday afternoon. And the company's press release is available on its website at pdsbiotech.com. In addition, this conference call is being webcast and will be archived on the company website for future reference. Before we begin, we need to remind everyone that on today's call, the company will be making forward-looking statements regarding potential
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)